SCHEMBL3479953

SCHEMBL3479953

CN1CCN(c2ccc3ccccc3c2)c2ccc(-c3nnco3)cc2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 1/20 0.41
SCN9A Q15858 1/20 0.41
LMNA P02545 4/20 0.38
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 3/20 0.38
HTT P42858 2/20 0.38
MAPT P10636 1/20 0.38
NOTUM Q6P988 7/20 0.37
MAPK1 P28482 2/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TLR8 Q9NR97 1/20 0.35
ROCK2 O75116 1/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A3 Q01959 2/20 0.35
SLC6A4 P31645 1/20 0.35
HPGD P15428 2/20 0.34
USP2 O75604 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3227698 0.88 SCN9A (0.42) SCN9ALMNAALDH1A1KDM4EHTT
SCHEMBL3229598 0.84 NOTUM (0.40) SCN9ALMNAALDH1A1KDM4EHTT
SCHEMBL3479969 0.84 SCN9A (0.41) SCN9ALMNAALDH1A1KDM4EHTT
SCHEMBL3479742 0.84 NOTUM (0.47) SCN9ALMNAALDH1A1KDM4EHTT
SCHEMBL3228678 0.84 HTR3A (0.41) HTR3ASCN9AKDM4EMAPTSMN1; SMN2
SCHEMBL3223159 0.82 NOTUM (0.41) SCN9ALMNAALDH1A1KDM4EHTT
SCHEMBL3479582 0.80 SLC6A2 (0.55) HTR3ASCN9AKDM4EMAPTSMN1; SMN2
SCHEMBL3235442 0.80 SCN9A (0.46) HTR3ASCN9A
SCHEMBL3479598 0.80 HTR3A (0.46) HTR3ASCN9AKDM4EMAPTSMN1; SMN2
SCHEMBL3232390 0.80 HTR3A (0.41) HTR3ASCN9AKDM4EMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D HTR3A 30/4885SCN9A 795/4885LMNA 3262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.